Tscan therapeutics to participate in the morgan stanley 19th annual global healthcare conference

Waltham, mass., sept. 02, 2021 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a biopharmaceutical company focused on the development of t-cell receptor (tcr) engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced that david southwell, president and chief executive officer, will participate in a virtual fireside chat at the morgan stanley 19th annual global healthcare conference on friday, september 10, 2021 at 4:15 p.m. et.
TCRX Ratings Summary
TCRX Quant Ranking